Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Household costs of seeking BCG vaccination in rural Guinea-Bissau.

Thysen SM, Byberg S, Martins JSD, Kallestrup P, Griffiths UK, Fisker AB.

Vaccine. 2019 Sep 3;37(37):5505-5508. doi: 10.1016/j.vaccine.2019.08.004. Epub 2019 Aug 9.

PMID:
31405635
2.

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.

Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team.

Clin Infect Dis. 2019 Mar 13. pii: ciy971. doi: 10.1093/cid/ciy971. [Epub ahead of print]

3.

A bibliometric analysis of systematic reviews on vaccines and immunisation.

Fernandes S, Jit M, Bozzani F, Griffiths UK, Scott JAG, Burchett HED.

Vaccine. 2018 Apr 19;36(17):2254-2261. doi: 10.1016/j.vaccine.2018.02.049. Epub 2018 Mar 22. Review.

4.

Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used.

Nymark LS, Sharma T, Miller A, Enemark U, Griffiths UK.

Vaccine. 2017 Dec 14;35(49 Pt B):6828-6841. doi: 10.1016/j.vaccine.2017.10.024. Epub 2017 Nov 13. Review.

5.

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.

Botwright S, Holroyd T, Nanda S, Bloem P, Griffiths UK, Sidibe A, Hutubessy RCW.

PLoS One. 2017 Oct 10;12(10):e0182663. doi: 10.1371/journal.pone.0182663. eCollection 2017.

6.

Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.

Byberg S, Fisker AB, Thysen SM, Rodrigues A, Enemark U, Aaby P, Benn CS, Griffiths UK.

Glob Health Action. 2017;10(1):1329968. doi: 10.1080/16549716.2017.1329968.

7.

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D.

PLoS One. 2017 Jun 2;12(6):e0177773. doi: 10.1371/journal.pone.0177773. eCollection 2017.

8.

Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.

Byberg S, Fisker AB, Rodrigues A, Balde I, Enemark U, Aaby P, Benn CS, Griffiths UK.

Trop Med Int Health. 2017 Jan;22(1):12-20. doi: 10.1111/tmi.12793. Epub 2016 Oct 28.

9.

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D.

BMC Public Health. 2016 Aug 19;16(1):834. doi: 10.1186/s12889-016-3517-8.

10.

Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?

Griffiths UK, Bozzani FM, Chansa C, Kinghorn A, Kalesha-Masumbu P, Rudd C, Chilengi R, Brenzel L, Schutte C.

Vaccine. 2016 Jul 29;34(35):4213-4220. doi: 10.1016/j.vaccine.2016.06.050. Epub 2016 Jun 28.

11.

Opportunities and challenges for implementing cost accounting systems in the Kenyan health system.

Kihuba E, Gheorghe A, Bozzani F, English M, Griffiths UK.

Glob Health Action. 2016 Jun 28;9:30621. doi: 10.3402/gha.v9.30621. eCollection 2016.

12.

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Howard N, Mounier-Jack S, Gallagher KE, Kabakama S, Griffiths UK, Feletto M, LaMontagne DS, Burchett HE, Watson-Jones D.

Hum Vaccin Immunother. 2016 Sep;12(9):2475-7. doi: 10.1080/21645515.2016.1178433. Epub 2016 May 9.

13.

New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impacts.

Torres-Rueda S, Burchett HE, Griffiths UK, Ongolo-Zogo P, Edengue JM, Kitaw Y, Molla M, Gelmon L, Onyango-Ouma W, Konate M, Mounier-Jack S.

Afr Health Sci. 2015 Sep;15(3):868-77. doi: 10.4314/ahs.v15i3.22.

14.

Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting.

Pitt C, Vassall A, Teerawattananon Y, Griffiths UK, Guinness L, Walker D, Foster N, Hanson K.

Health Econ. 2016 Feb;25 Suppl 1:1-5. doi: 10.1002/hec.3319. No abstract available.

15.

Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?

Griffiths UK, Legood R, Pitt C.

Health Econ. 2016 Feb;25 Suppl 1:29-41. doi: 10.1002/hec.3312. Epub 2016 Jan 17.

16.

Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya.

Brooker SJ, Mwandawiro CS, Halliday KE, Njenga SM, Mcharo C, Gichuki PM, Wasunna B, Kihara JH, Njomo D, Alusala D, Chiguzo A, Turner HC, Teti C, Gwayi-Chore C, Nikolay B, Truscott JE, Hollingsworth TD, Balabanova D, Griffiths UK, Freeman MC, Allen E, Pullan RL, Anderson RM.

BMJ Open. 2015 Oct 19;5(10):e008950. doi: 10.1136/bmjopen-2015-008950.

17.

Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?

Pan XF, Griffiths UK, Pennington M, Yu H, Jit M.

Vaccine. 2015 Nov 17;33(46):6164-72. doi: 10.1016/j.vaccine.2015.09.081. Epub 2015 Oct 2. Review.

18.

Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.

Le P, Griffiths UK, Anh DD, Franzini L, Chan W, Swint JM.

Vaccine. 2015 Aug 26;33(36):4639-46. doi: 10.1016/j.vaccine.2015.05.050. Epub 2015 Jun 1.

19.

Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Laurence YV, Griffiths UK, Vassall A.

Pharmacoeconomics. 2015 Sep;33(9):939-55. doi: 10.1007/s40273-015-0279-6. Review.

20.

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

Knight GM, Griffiths UK, Sumner T, Laurence YV, Gheorghe A, Vassall A, Glaziou P, White RG.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5. doi: 10.1073/pnas.1404386111. Epub 2014 Oct 6.

21.

Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system.

Mounier-Jack S, Burchett HE, Griffiths UK, Konate M, Diarra KS.

Glob Health Sci Pract. 2014 Jan 15;2(1):117-29. doi: 10.9745/GHSP-D-13-00130. eCollection 2014 Feb.

22.

The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.

Burchett HE, Mounier-Jack S, Torres-Rueda S, Griffiths UK, Ongolo-Zogo P, Rulisa S, Edengue JM, Chavez E, Kitaw Y, Molla M, Konate M, Gelmon L, Onyango-Ouma W, Lagarde M, Mills A.

Vaccine. 2014 Nov 12;32(48):6505-12.

23.

The economic burden of pneumonia and meningitis among children less than five years old in Hanoi, Vietnam.

Le P, Griffiths UK, Anh DD, Franzini L, Chan W, Pham H, Swint JM.

Trop Med Int Health. 2014 Nov;19(11):1321-7. doi: 10.1111/tmi.12370. Epub 2014 Aug 18.

24.

Burden of disease in adults admitted to hospital in a rural region of coastal Kenya: an analysis of data from linked clinical and demographic surveillance systems.

Etyang AO, Munge K, Bunyasi EW, Matata L, Ndila C, Kapesa S, Owiti M, Khandwalla I, Brent AJ, Tsofa B, Kabibu P, Morpeth S, Bauni E, Otiende M, Ojal J, Ayieko P, Knoll MD, Smeeth L, Williams TN, Griffiths UK, Scott JA.

Lancet Glob Health. 2014 Apr;2(4):e216-24.

25.

Measuring the health systems impact of disease control programmes: a critical reflection on the WHO building blocks framework.

Mounier-Jack S, Griffiths UK, Closser S, Burchett H, Marchal B.

BMC Public Health. 2014 Mar 25;14:278. doi: 10.1186/1471-2458-14-278.

26.

Health systems analysis of eye care services in Zambia: evaluating progress towards VISION 2020 goals.

Bozzani FM, Griffiths UK, Blanchet K, Schmidt E.

BMC Health Serv Res. 2014 Feb 28;14:94. doi: 10.1186/1472-6963-14-94.

27.

Cost-effectiveness of eye care services in Zambia.

Griffiths UK, Bozzani FM, Gheorghe A, Mwenge L, Gilbert C.

Cost Eff Resour Alloc. 2014 Feb 25;12(1):6. doi: 10.1186/1478-7547-12-6.

28.

Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions.

Usuf E, Mackenzie G, Lowe-Jallow Y, Boye B, Atherly D, Suraratdecha C, Griffiths UK.

Vaccine. 2014 Apr 7;32(17):1975-81. doi: 10.1016/j.vaccine.2014.01.045. Epub 2014 Feb 3.

PMID:
24503271
29.

Costs of eye care services: prospective study from a faith-based hospital in Zambia.

Griffiths UK, Bozzani F, Muleya L, Mumba M.

Ophthalmic Epidemiol. 2015 Feb;22(1):43-51. doi: 10.3109/09286586.2013.839800. Epub 2013 Oct 4.

PMID:
24093456
30.

Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.

Ayieko P, Griffiths UK, Ndiritu M, Moisi J, Mugoya IK, Kamau T, English M, Scott JA.

PLoS One. 2013 Jun 24;8(6):e67324. doi: 10.1371/journal.pone.0067324. Print 2013.

31.

Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M.

J Pediatr. 2013 Jul;163(1 Suppl):S60-72. doi: 10.1016/j.jpeds.2013.03.032.

32.
33.

Effect of increasing active travel in urban England and Wales on costs to the National Health Service.

Jarrett J, Woodcock J, Griffiths UK, Chalabi Z, Edwards P, Roberts I, Haines A.

Lancet. 2012 Jun 9;379(9832):2198-205. doi: 10.1016/S0140-6736(12)60766-1.

PMID:
22682466
34.

Costs of meningitis sequelae in children in Dakar, Senegal.

Griffiths UK, Dieye Y, Fleming J, Hajjeh R, Edmond K.

Pediatr Infect Dis J. 2012 Nov;31(11):e189-95. doi: 10.1097/INF.0b013e3182615297.

PMID:
22668806
35.

Economic burden of acute lower respiratory tract infection in South African children.

Sinha A, Kim S, Ginsberg G, Franklin H, Kohberger R, Strutton D, Madhi SA, Griffiths UK, Klugman KP.

Paediatr Int Child Health. 2012 May;32(2):65-73. doi: 10.1179/2046905512Y.0000000010.

PMID:
22595212
36.

Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials.

Griffiths UK, Clark A, Gessner B, Miners A, Sanderson C, Sedyaningsih ER, Mulholland KE.

Epidemiol Infect. 2012 Aug;140(8):1343-55. doi: 10.1017/S0950268812000957. Epub 2012 May 14. Review.

37.

Measles in the 21st century.

Mulholland EK, Griffiths UK, Biellik R.

N Engl J Med. 2012 May 10;366(19):1755-7. doi: 10.1056/NEJMp1202396. No abstract available.

38.

New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.

Burchett HE, Mounier-Jack S, Griffiths UK, Biellik R, Ongolo-Zogo P, Chavez E, Sarma H, Uddin J, Konate M, Kitaw Y, Molla M, Wakasiaka S, Gilson L, Mills A.

Health Policy Plan. 2012 May;27 Suppl 2:ii5-16. doi: 10.1093/heapol/czs035.

PMID:
22513732
39.

Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.

Griffiths UK, Anigbogu B, Nanchahal K.

Appl Health Econ Health Policy. 2012 May 1;10(3):145-62. doi: 10.2165/11599250-000000000-00000. Review.

PMID:
22439628
40.

The cost of outpatient pneumonia in children <5 years of age in Fiji.

Temple B, Griffiths UK, Mulholland EK, Ratu FT, Tikoduadua L, Russell FM.

Trop Med Int Health. 2012 Feb;17(2):197-203. doi: 10.1111/j.1365-3156.2011.02897.x. Epub 2011 Oct 18.

41.

National decision-making on adopting new vaccines: a systematic review.

Burchett HE, Mounier-Jack S, Griffiths UK, Mills AJ.

Health Policy Plan. 2012 May;27 Suppl 2:ii62-76. doi: 10.1093/heapol/czr049. Epub 2011 Jul 6. Review.

PMID:
21733989
42.

Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan.

Griffiths UK, Clark A, Shimanovich V, Glinskaya I, Tursunova D, Kim L, Mosina L, Hajjeh R, Edmond K.

PLoS One. 2011;6(6):e21472. doi: 10.1371/journal.pone.0021472. Epub 2011 Jun 24.

43.

Impact of measles elimination activities on immunization services and health systems: findings from six countries.

Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, Ongolo-Zogo P, Sadykova U, Sarma H, Teixeira M, Uddin J, Dabbagh A, Griffiths UK.

J Infect Dis. 2011 Jul;204 Suppl 1:S82-9. doi: 10.1093/infdis/jir091.

PMID:
21666218
44.

How can measles eradication strengthen health care systems?

Griffiths UK, Mounier-Jack S, Oliveira-Cruz V, Balabanova D, Hanvoravongchai P, Ongolo P.

J Infect Dis. 2011 Jul;204 Suppl 1:S78-81. doi: 10.1093/infdis/jir090.

PMID:
21666217
45.

Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa.

Griffiths UK, Santos AC, Nundy N, Jacoby E, Matthias D.

Vaccine. 2011 Jan 29;29(5):969-75. doi: 10.1016/j.vaccine.2010.11.038. Epub 2010 Nov 27.

PMID:
21115059
46.

Measles eradication: past is prologue.

Heymann DL, Fine PE, Griffiths UK, Hall AJ, Mounier-Jack S.

Lancet. 2010 Nov 20;376(9754):1719-20. doi: 10.1016/S0140-6736(10)61934-4. No abstract available.

PMID:
21093636
47.

Global use of Haemophilus influenzae type b conjugate vaccine.

Ojo LR, O'Loughlin RE, Cohen AL, Loo JD, Edmond KM, Shetty SS, Bear AP, Privor-Dumm L, Griffiths UK, Hajjeh R.

Vaccine. 2010 Oct 8;28(43):7117-22. doi: 10.1016/j.vaccine.2010.07.074. Epub 2010 Aug 4.

PMID:
20691265
48.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.

Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

PMID:
20659515
49.

Prospective cohort study of disabling sequelae and quality of life in children with bacterial meningitis in urban Senegal.

Edmond K, Dieye Y, Griffiths UK, Fleming J, Ba O, Diallo N, Mulholland K.

Pediatr Infect Dis J. 2010 Nov;29(11):1023-9. doi: 10.1097/INF.0b013e3181e598ea.

PMID:
20517172
50.

Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.

Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I.

Lancet Infect Dis. 2010 May;10(5):317-28. doi: 10.1016/S1473-3099(10)70048-7. Review.

Supplemental Content

Loading ...
Support Center